icon icon
icon
icon
Ask
icon
icon

Marker Therapeutics

MRKR

MRKR Marker Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    MRKR Chart
    See on advanced chart >

    About

    Marker Therapeutics, Inc., a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker's cell therapy technology...
    Read More
    • Highlight
      A clinical-stage immuno-oncology company that develops next-generation T cell-based immunotherapies for hematological malignancies and solid tumor indications
      • Industry
      Biotechnology
    • Exchange
      NASDAQ
    • Listing Date
      11/08/2016
    • Established Date
      Invalid Date
    • Full-time Employees
      8
    • Address
      3200 Southwest Freeway Suite 2500 Houston Texas 77027
    • Tel
      1-713-4006400
    • Website
      www.markertherapeutics.com
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock